News
Heparin’s COVID-19 benefit greatest in moderately ill patients
August 13, 2021
A multiplatform trial reported that therapeutic heparin improved outcomes in moderately ill COVID-19 patients but not in critically ill patients.
News
Tachycardia syndrome may be distinct marker for long COVID
August 13, 2021
Post-COVID patients with palpitations or chest pain should undergo a cardiac workup, new research suggests. The data also shed light on potential treatments.
News
HM administrators plan for 2021 and beyond
August 13, 2021
“If there was ever doubt that the hospitalists are the beating heart of the hospital, this doubt is now gone,” said Elda Dede, FHM.
News
FDA authorizes booster shot for immunocompromised Americans
August 13, 2021
Those eligible for a third dose include solid organ transplant recipients, those undergoing cancer treatments, and people with autoimmune diseases that suppress their immune systems.
News
Move from awareness to action to combat racism in medicine
August 12, 2021
Calls to action to address structural racism include learning from policies, prioritizing voting, and educating children.
News
SHM’s Center for Quality Improvement to partner on NIH grant
August 12, 2021
Study will identify interventions to rapidly improve care for children hospitalized with respiratory illnesses.
News
Febrile infant guideline allows wiggle room on hospital admission, testing
August 12, 2021
Evidence-based guidelines use language to guide, but not direct, clinicians in balancing the risks of infections and invasive procedures.
News
Hospitals struggle to find nurses, beds, even oxygen as Delta surges
August 12, 2021
“We have a vaccine, which is the key to ending this pandemic and people just refuse to take it, and so I think we’re very frustrated.”
News
Pandemic demand for NPs soars, softens for primary care: Report
August 12, 2021
“NPs are coming into their own in a market that puts a premium on easy access to care and cost containment.”
News
FDA may okay COVID booster for vulnerable adults before weekend: Media
August 12, 2021
Between one-third and one-half of immunocompromised patients who didn’t develop detectable levels of virus-fighting antibodies after two doses of a COVID vaccine will respond to a third dose.